Inmunogenómica y evolución de las neoplasias linfoides
Publicaciones destacadas
-
The biology and evolution of Richter transformation in chronic lymphocytic leukemia
Nadeu, Ferran; Efremov, Dimitar G; Efremov, Dimitar G;Referencia:SEMINARS IN CANCER BIOLOGY 2026.
-
Disease-specific U1 spliceosomal RNA mutations in mature B-cell neoplasms
Nadeu, Ferran; Shuai, Shimin; Clot, Guillem; Hilton, Laura K; Hilton, Laura K;(...)Stein, Lincoln D; Stein, Lincoln D; Puente, Xose S; Puente, Xose S; Campo, Elias.Referencia:LEUKEMIA 2025.
-
Chronic lymphocytic leukemia patient-derived xenografts recapitulate clonal evolution to Richter transformation
Playa-Albinyana, Heribert; Arenas, Fabian; Royo, Romina; Giro, Ariadna; Lopez-Oreja, Irene;(...)Garcia-Roves, Pablo M; Garcia-Roves, Pablo M; Campo, Elias; Nadeu, Ferran; Colomer, Dolors.Referencia:LEUKEMIA 2024.
-
All-CLL: A Capture-based Next-generation Sequencing Panel for the Molecular Characterization of Chronic Lymphocytic Leukemia
Lopez-Oreja, Irene; Lopez-Guerra, Monica; Correa, Juan; Mozas, Pablo; Muntanola, Ana;(...)Bea, Silvia; Jares, Pedro; Campo, Elias; Colomer, Dolors; Nadeu, Ferran.Referencia:HemaSphere 2023.
-
Molecular map of chronic lymphocytic leukemia and its impact on outcome
Knisbacher, Binyamin A; Knisbacher, Binyamin A; Lin, Ziao; Hahn, Cynthia K; Hahn, Cynthia K;(...)Stilgenbauer, Stephan; Wu, Catherine J; Wu, Catherine J; Campo, Elias; Getz, Gad.Referencia:NATURE GENETICS 2022.
-
Detection of early seeding of Richter transformation in chronic lymphocytic leukemia
Nadeu, Ferran; Royo, Romina; Massoni-Badosa, Ramon; Garcia-Torre, Beatriz; Duran-Ferrer, Marti;(...)Capella-Gutierrez, Salvador; Li Gelp, Josep; Lopez-Bigas, Niiria; Garcia-Roves, Pablo M; Martin-Subero, Jose, I.Referencia:NATURE MEDICINE 2022.
-
IGLV3-21R110 identifies an aggressive biological subtype of chronic lymphocytic leukemia with intermediate epigenetics
Nadeu, Ferran; Royo, Romina; Clot, Guillem; Duran-Ferrer, Marti; Navarro, Alba;(...)Puente, Xose S; Martin-Subero, Jose I; Martin-Subero, Jose I; Delgado, Julio; Campo, Elias.Referencia:BLOOD 2021.
-
Genomic and epigenomic insights into the origin, pathogenesis and clinical behavior of mantle cell lymphoma subtypes
Nadeu, Ferran; Martin-Garcia, David; Clot, Guillem; Diaz-Navarro, Ander; Duran-Ferrer, Marti;(...)Martin-Subero, Jose, I; Puente, Xose S; Puente, Xose S; Bea, Silvia; Campo, Elias.Referencia:BLOOD 2020.
-
IgCaller for reconstructing immunoglobulin gene rearrangements and oncogenic translocations from whole-genome sequencing in lymphoid neoplasms
Nadeu, Ferran; Mas-de-les-Valls, Rut; Navarro, Alba; Royo, Romina; Martin, Silvia;(...)Campbell, Peter J; Campbell, Peter J; Bea, Silvia; Maura, Francesco; Campo, Elias.Referencia:Nature Communications 2020.
-
Clinical impact of clonal and subclonal TP53, SF3B1, BIRC3, NOTCH1, and ATM mutations in chronic lymphocytic leukemia
Nadeu, Ferran; Delgado, Julio; Royo, Cristina; Baumann, Tycho; Stankovic, Tatjana;(...)Puente, Xose S; Puente, Xose S; Lopez-Otin, Carlos; Enjuanes, Anna; Campo, Elias.Referencia:BLOOD 2016.
